Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide
Molecular Neurobiology · 2024-09 · 61 (9) · 7066-7074
DOI: 10.1007/s12035-024-04041-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, online erschienen am 17.02.2024. Verfasst von Wenwu Kan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310011, Zhejiang, China. Hauptthemen laut MEDLINE: Temozolomide, DNA Methyltransferase 3B, DNA (Cytosine-5-)-Methyltransferases, Glioblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Traditional Chinese Medicine Administration.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most common malignant brain tumor and has the poorest prognosis attributed to its chemoresistance to temozolomide (TMZ), the first-line drug for treating GBM. TMZ resistance represents a significant obstacle to successful GBM treatment, necessitating the development of new strategies to overcome this resistance and augment the chemosensitivity of GBM cells to TMZ. This study established a TMZ-resistant U251 (U251-TMZ) cell line by exposing it to increasing doses of TMZ in vitro. We focused on the DNA methyltransferase 3B (DNMT3B) gene, phosphorylated Akt (p-Akt), total Akt (t-Akt), phosphorylated PI3K (p-PI3K), and total PI3K (t-PI3K) protein expression. Results showed that the DNMT3B gene was significantly upregulated in the U251-TMZ cell line. The p-Akt and p-PI3K protein expression in U251-TMZ cells was also significantly elevated. Moreover, we found that DNMT3B downregulation was correlated with the increased chemosensitivity of GBM cells to TMZ. LY294002 suppressed the PI3K/Akt signaling pathway, leading to a notable inhibition of PI3K phosphorylation and a significant decrease in DNMT3B expression in U251-TMZ cells. Given that DNMT3B expression is mediated by the PI3K/Akt signaling pathway, its downregulation further increased the chemosensitivity of GBM cells to TMZ and therefore is a promising therapeutic for GBM treatment. Our results suggested that DNMT3B downregulation can inhibit the proliferation of GBM cells and induce GBM cell apoptosis in vitro. In addition, the PI3K/Akt signaling pathway plays an important role in the chemosensitivity of GBM cells to TMZ by regulating DNMT3B expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310011, Zhejiang, China.
- The First Clinical Medical College of Zhejiang, Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
- Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310011, Zhejiang, China. xh_wangcheng@163.com.
Förderung
- Zhejiang Traditional Chinese Medicine Administration
Zitieren
APA
Kan, W., Gao, L., Chen, J., Chen, L., Zhang, G., Hao, B., He, M., Chen, X., & Wang, C. (2024). Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Molecular Neurobiology, 61(9), 7066-7074. https://doi.org/10.1007/s12035-024-04041-7
Vancouver
Kan W, Gao L, Chen J, Chen L, Zhang G, Hao B, et al. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Molecular Neurobiology. 2024;61(9):7066-7074. doi:10.1007/s12035-024-04041-7
BibTeX
@article{Kan2024,
author = {Kan, Wenwu and Gao, Linhui and Chen, Jingnan and Chen, Li and Zhang, Guojun and Hao, Bilie and He, Min and Chen, Xudong and Wang, Cheng},
title = {Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide},
journal = {Molecular Neurobiology},
year = {2024},
volume = {61},
number = {9},
pages = {7066--7074},
doi = {10.1007/s12035-024-04041-7}
}
EUVIMED